Glaukos Corp Note 2.750% 6/1 (Principal)
|
6.7 |
$325M |
|
272M |
1.19 |
Nuvalent Inc-a
(NUVL)
|
5.4 |
$262M |
|
19M |
13.56 |
Viatris
(VTRS)
|
4.5 |
$217M |
|
21M |
10.47 |
Adapthealth Corp Common Stock
(AHCO)
|
4.1 |
$201M |
|
11M |
18.04 |
Neurocrine Biosciences
(NBIX)
|
4.0 |
$196M |
|
2.0M |
97.48 |
Invitae Corp Note 2.000% 9/0 (Principal)
|
3.4 |
$163M |
|
207M |
0.79 |
Aerie Pharmaceuticals Note 1.500%10/0 (Principal)
|
2.7 |
$133M |
|
157M |
0.85 |
Ionis Pharmaceuticals Note 4/0 (Principal)
|
2.4 |
$117M |
|
128M |
0.92 |
Natera Note 2.250% 5/0 (Principal)
|
2.3 |
$112M |
|
91M |
1.23 |
Sarepta Therapeutics DBCV 1.500%11/1
|
2.3 |
$112M |
|
89M |
1.26 |
Biogen Idec Call Option
(BIIB)
|
2.1 |
$102M |
|
500k |
203.94 |
Envista Holdings Corporation Note 2.375% 6/0 (Principal)
|
2.1 |
$100M |
|
53M |
1.91 |
Silk Road Medical Inc Common
|
2.0 |
$97M |
|
2.7M |
36.39 |
Tabula Rasa Healthcare Note 1.750% 2/1 (Principal)
|
2.0 |
$97M |
|
145M |
0.67 |
Gilead Sciences
(GILD)
|
2.0 |
$96M |
|
1.6M |
61.81 |
Nuvasive Note 1.000% 6/0 (Principal)
|
1.9 |
$94M |
|
97M |
0.97 |
Pacira Biosciences Note 0.750% 8/0 (Principal)
|
1.8 |
$85M |
|
82M |
1.04 |
Deciphera Pharmaceuticals
|
1.7 |
$82M |
|
6.3M |
13.15 |
Apellis Pharmaceuticals Note 3.500% 9/1 (Principal)
|
1.6 |
$77M |
|
52M |
1.47 |
Nuvasive Note 0.375% 3/1 (Principal)
|
1.5 |
$72M |
|
80M |
0.90 |
Insmed Note 1.750% 1/1 (Principal)
|
1.5 |
$71M |
|
75M |
0.94 |
ImmunoGen
|
1.4 |
$68M |
|
15M |
4.50 |
Insulet Corp Note 0.375% 9/0 (Principal)
|
1.4 |
$66M |
|
58M |
1.15 |
Mirum Pharmaceuticals
(MIRM)
|
1.3 |
$63M |
|
3.2M |
19.46 |
Day One Biopharmaceuticals I
(DAWN)
|
1.3 |
$63M |
|
3.5M |
17.90 |
Accolade Note 0.500% 4/0 (Principal)
|
1.2 |
$59M |
|
93M |
0.64 |
Nevro Corp Note 2.750% 4/0 (Principal)
|
1.2 |
$58M |
|
61M |
0.95 |
Caremax Com Cl A
|
1.2 |
$58M |
|
16M |
3.63 |
Guardant Health Note 11/1 (Principal)
|
1.2 |
$57M |
|
89M |
0.64 |
Intercept Pharmaceuticals In Note 3.250% 7/0 (Principal)
|
1.2 |
$56M |
|
58M |
0.97 |
Cogent Biosciences
(COGT)
|
1.1 |
$53M |
|
5.9M |
9.02 |
Pulmonx Corp
(LUNG)
|
1.1 |
$51M |
|
3.5M |
14.72 |
Iveric Bio
|
1.0 |
$50M |
|
5.2M |
9.62 |
Centene Corporation
(CNC)
|
1.0 |
$49M |
|
579k |
84.61 |
Oak Str Health Note 3/1
|
1.0 |
$49M |
|
68M |
0.71 |
Kura Oncology
(KURA)
|
1.0 |
$48M |
|
2.6M |
18.33 |
Glaukos
(GKOS)
|
1.0 |
$47M |
|
1.0M |
45.42 |
Molina Healthcare
(MOH)
|
1.0 |
$47M |
|
167k |
279.61 |
Cytokinetics Com New
(CYTK)
|
0.9 |
$46M |
|
1.2M |
39.29 |
Merus N V
(MRUS)
|
0.9 |
$45M |
|
2.0M |
22.64 |
Dynavax Technologies Corp Note 2.500% 5/1 (Principal)
|
0.9 |
$45M |
|
30M |
1.49 |
Livongo Health Note 0.875% 6/0 (Principal)
|
0.9 |
$42M |
|
50M |
0.85 |
Evolus
(EOLS)
|
0.9 |
$42M |
|
3.6M |
11.60 |
1life Healthcare Note 3.000% 6/1 (Principal)
|
0.8 |
$40M |
|
49M |
0.83 |
Brookdale Senior Living
(BKD)
|
0.8 |
$39M |
|
8.6M |
4.54 |
Aerie Pharmaceuticals
|
0.7 |
$35M |
|
4.7M |
7.50 |
Ptc Therapeutics Note 1.500% 9/1 (Principal)
|
0.7 |
$33M |
|
32M |
1.04 |
Edgewise Therapeutics
(EWTX)
|
0.6 |
$31M |
|
3.9M |
7.96 |
Hillevax
(HLVX)
|
0.6 |
$29M |
|
2.6M |
10.93 |
Pharvaris N V
(PHVS)
|
0.5 |
$26M |
|
1.2M |
22.10 |
Ptc Therapeutics Note 3.000% 8/1 (Principal)
|
0.5 |
$26M |
|
25M |
1.00 |
Horizon Therapeutics Pub L SHS
|
0.5 |
$25M |
|
313k |
79.76 |
Novavax Note 3.750% 2/0 (Principal)
|
0.5 |
$25M |
|
25M |
0.99 |
Singular Genomics Systems In
|
0.5 |
$24M |
|
6.3M |
3.82 |
Sema4 Holdings Corp Com Cl A
|
0.5 |
$24M |
|
19M |
1.26 |
Bellus Health Com New
|
0.5 |
$23M |
|
2.5M |
9.24 |
Organogenesis Hldgs
(ORGO)
|
0.4 |
$22M |
|
4.4M |
4.88 |
Phreesia
(PHR)
|
0.4 |
$21M |
|
857k |
25.01 |
Syndax Pharmaceuticals
(SNDX)
|
0.4 |
$21M |
|
1.1M |
19.24 |
Amedisys
(AMED)
|
0.4 |
$21M |
|
199k |
105.12 |
Tarsus Pharmaceuticals
(TARS)
|
0.4 |
$19M |
|
1.3M |
14.60 |
Insmed Com Par $.01
(INSM)
|
0.4 |
$19M |
|
961k |
19.72 |
Xeris Biopharma Holdings Note 5.000% 7/1 (Principal)
|
0.4 |
$18M |
|
18M |
0.98 |
Revolution Medicines
(RVMD)
|
0.4 |
$17M |
|
892k |
19.49 |
Oncology Institu
(TOI)
|
0.4 |
$17M |
|
3.4M |
5.06 |
Pacira Pharmaceuticals
(PCRX)
|
0.4 |
$17M |
|
292k |
58.30 |
Alphatec Hldgs Com New
(ATEC)
|
0.3 |
$16M |
|
2.4M |
6.54 |
Anaptysbio Inc Common
(ANAB)
|
0.3 |
$16M |
|
772k |
20.30 |
Da32 Life Scnce Tec Acqstn C Class A Com
|
0.3 |
$16M |
|
1.6M |
9.69 |
Health Catalyst Note 2.500% 4/1 (Principal)
|
0.3 |
$14M |
|
15M |
0.90 |
Inozyme Pharma
(INZY)
|
0.3 |
$13M |
|
2.7M |
4.77 |
Profound Med Corp Com New
(PROF)
|
0.3 |
$13M |
|
1.7M |
7.29 |
Kezar Life Sciences
|
0.2 |
$12M |
|
1.4M |
8.27 |
Larimar Therapeutics
(LRMR)
|
0.2 |
$11M |
|
5.8M |
1.96 |
Tg Therapeutics
(TGTX)
|
0.2 |
$11M |
|
2.7M |
4.25 |
Alector
(ALEC)
|
0.2 |
$11M |
|
1.1M |
10.16 |
Foghorn Therapeutics
(FHTX)
|
0.2 |
$11M |
|
778k |
13.60 |
Eucrates Biomedical Acqu Cor SHS
|
0.2 |
$9.9M |
|
1000k |
9.90 |
Sarissa Capital Acquisitn Cl A
|
0.2 |
$9.9M |
|
1000k |
9.89 |
Medtech Acquisition Corp Com Cl A
|
0.2 |
$9.8M |
|
1000k |
9.85 |
Senior Connect Acquisitn Cor Com Cl A
|
0.2 |
$9.8M |
|
1.0M |
9.84 |
Revolution Healthcar Aq Corp Class A Com
|
0.2 |
$9.8M |
|
1.0M |
9.77 |
Pepgen
(PEPG)
|
0.2 |
$9.5M |
|
954k |
9.93 |
Turmeric Acquisition Corp Cl A
|
0.2 |
$7.4M |
|
750k |
9.93 |
Nkarta
(NKTX)
|
0.2 |
$7.4M |
|
600k |
12.32 |
Ignyte Acquisition Corp
|
0.1 |
$7.1M |
|
725k |
9.86 |
Apollo Endosurgery
|
0.1 |
$6.4M |
|
1.8M |
3.65 |
Xilio Therapeutics
(XLO)
|
0.1 |
$6.1M |
|
2.1M |
2.92 |
Outset Med
(OM)
|
0.1 |
$6.0M |
|
401k |
14.86 |
Benefitfocus Note 1.250%12/1 (Principal)
|
0.1 |
$5.9M |
|
6.5M |
0.91 |
Graybug Vision Com Shs
|
0.1 |
$5.8M |
|
5.3M |
1.09 |
An2 Therapeutics
(ANTX)
|
0.1 |
$5.6M |
|
717k |
7.75 |
Neogenomics Note 1.250% 5/0 (Principal)
|
0.1 |
$5.4M |
|
6.5M |
0.84 |
Orion Acquisition Corp Com Cl A
|
0.1 |
$4.9M |
|
500k |
9.80 |
Nyxoah S A SHS
(NYXH)
|
0.1 |
$4.2M |
|
455k |
9.20 |
Orchard Therapeutics Ads
|
0.1 |
$4.1M |
|
6.9M |
0.58 |
Oncorus
|
0.1 |
$4.0M |
|
3.1M |
1.26 |
Werewolf Therapeutics
(HOWL)
|
0.1 |
$3.9M |
|
958k |
4.09 |
Quantum Si Com Cl A
(QSI)
|
0.1 |
$3.2M |
|
1.4M |
2.32 |
Kinnate Biopharma
|
0.1 |
$3.2M |
|
250k |
12.61 |
Acutus Medical
(AFIB)
|
0.1 |
$3.0M |
|
2.6M |
1.12 |
Annexon
(ANNX)
|
0.0 |
$2.2M |
|
584k |
3.77 |
Delcath Sys Com New
(DCTH)
|
0.0 |
$2.0M |
|
500k |
3.99 |
89bio
(ETNB)
|
0.0 |
$1.6M |
|
506k |
3.22 |
Medavail Holdings Ord
|
0.0 |
$1.3M |
|
837k |
1.53 |
Rhythm Pharmaceuticals
(RYTM)
|
0.0 |
$1.2M |
|
291k |
4.15 |
The Oncology Institute *w Exp 11/15/202
(TOIIW)
|
0.0 |
$625k |
|
1.3M |
0.50 |
Roivant Sciences *w Exp 09/30/202
|
0.0 |
$600k |
|
1.0M |
0.60 |
Cabaletta Bio
(CABA)
|
0.0 |
$492k |
|
464k |
1.06 |
Caremax *w Exp 06/08/202
|
0.0 |
$484k |
|
672k |
0.72 |
Butterfly Network *w Exp 02/12/202
(BFLY.WS)
|
0.0 |
$296k |
|
733k |
0.40 |
Quantum Si *w Exp 06/10/202
(QSIAW)
|
0.0 |
$188k |
|
333k |
0.56 |
Somalogic *w Exp 08/31/202
|
0.0 |
$91k |
|
120k |
0.76 |
Ignyte Acquisition Corp *w Exp 01/05/202
|
0.0 |
$76k |
|
363k |
0.21 |
Revolution Healthcar Aq Corp *w Exp 12/31/202
|
0.0 |
$49k |
|
200k |
0.24 |
Nuvation Bio *w Exp 07/07/202
(NUVB.WS)
|
0.0 |
$47k |
|
167k |
0.28 |
Senior Connect Acquisitn Cor *w Exp 12/31/202
|
0.0 |
$35k |
|
500k |
0.07 |
Sarissa Capital Acquisitn *w Exp 10/23/202
|
0.0 |
$33k |
|
333k |
0.10 |
Surrozen *w Exp 08/01/203
(SRZNW)
|
0.0 |
$32k |
|
167k |
0.19 |
Medtech Acquisition Corp *w Exp 12/22/202
|
0.0 |
$28k |
|
333k |
0.08 |
Eucrates Biomedical Acqu Cor *w Exp 10/23/202
|
0.0 |
$22k |
|
333k |
0.07 |
Turmeric Acquisition Corp *w Exp 10/08/202
|
0.0 |
$19k |
|
250k |
0.08 |
Orion Acquisition Corp *w Exp 02/19/202
|
0.0 |
$11k |
|
125k |
0.09 |
Windtree Therapeutics
|
0.0 |
$8.0k |
|
20k |
0.40 |
Eucrates Biomedical Acqu Cor Unit 10/23/2027
|
0.0 |
$0 |
|
1.00 |
0.00 |
Sarissa Capital Acquisitn Unit 10/23/2027
|
0.0 |
$0 |
|
1.00 |
0.00 |
Medtech Acquisition Corp Unit 12/18/2025
|
0.0 |
$0 |
|
1.00 |
0.00 |